• clientsupport@thelansis.com
  • Mon – Fri | 08:00 – 20:00, Sat – Sun: Closed
  • Contact Us
Sign in/Register
  • About Us
    • Who We Are
    • Why Thelansis
    • Our Mission, Our Focus, Our Vision
    • Our Team
    • Key Clients
  • Report & Insights
    • Market Outlook and Forecast
    • Epidemiology Insights and Forecast
    • Current Treatment Insights
    • Emerging Therapy, Unmet Needs and TPP Insights
    • Market Access and Reimbursement Insights
  • Strategy Products
    • Epilansis
    • Payerpro360
    • Analog Tool
  • Consulting Services
    • Portfolio Optimization
    • Target Product Profile (TPP) Analysis
    • Market Access
    • Market Forecasting
    • Conference Coverage
  • Media
    • Case Studies
    • Blogs
ThelansisThelansis
  • About Us

    • About Us

      • Who We Are
      • Why Thelansis
      • Mission, Focus, and Vision
      • Our Team
      • Key Clients
  • Report & Insights
      • Market Outlook and Forecast
      • Epidemiology Insights and Forecast
      • Current Treatment Insights
      • Emerging Therapy, Unmet Needs and TPP Insights
      • Market Access and Reimbursement Insights
  • Strategy Products
      • EpiLansis
      • PayerPro360
      • Analog Tool
  • Consulting Services
      • Portfolio Optimization
      • Target Product Profile (TPP) Analysis
      • Market Access
      • Market Forecasting
      • Conference Coverage
  • Media
      • Case Studies
      • Blogs
Report Library
  • About Us
    • Who We Are
    • Why Thelansis
    • Our Mission, Our Focus, Our Vision
    • Our Team
    • Key Clients
  • Report & Insights
    • Market Outlook and Forecast
    • Epidemiology Insights and Forecast
    • Current Treatment Insights
    • Emerging Therapy, Unmet Needs and TPP Insights
    • Market Access and Reimbursement Insights
  • Strategy Products
    • Epilansis
    • Payerpro360
    • Analog Tool
  • Consulting Services
    • Portfolio Optimization
    • Target Product Profile (TPP) Analysis
    • Market Access
    • Market Forecasting
    • Conference Coverage
  • Media
    • Case Studies
    • Blogs

Press Release

  • /
  • Press Release
Press Release on Pulmonary Arterial Hypertension (PAH)
May 20, 2021

Pulmonary Arterial Hypertension (PAH) – Press Release

by Thelansis
0 0
Press Release on Crohn’s Disease (CD)
May 24, 2021

Crohn’s Disease (CD) – Press Release

by Thelansis
0 0
Press Release on Chemotherapy-Induced Peripheral Neuropathy (CIPN)
July 21, 2021

Chemotherapy-Induced Peripheral Neuropathy (CIPN) – Press Release

by Thelansis
0 0

Need customize support?

Thelansis also caters to your specific needs by providing customized reports that satisfy your organizational requirements. Get on-demand customization of the report’s scope to exactly meet your needs.

Ask for a demo

Need customize support?

Thelansis also caters to your specific needs by providing customized reports that satisfy your organizational requirements. Get on-demand customization of the report’s scope to exactly meet your needs.
GET IN TOUCH

Thelansis Knowledge Partners LLP is a global life sciences market research firm supporting pharmaceutical, biotechnology, and medical device companies with specialized insights.

+91 124-4937605
clientsupport@thelansis.com

Report & Insights

  • Market Outlook and Forecast
  • Epidemiology Insights and Forecast
  • Current Treatment Insights
  • Emerging Therapy, Unmet Needs and TPP Insights
  • Market Access and Reimbursement Insights

Other Links

  • About Us
  • Our Team
  • Report Library
  • Case Studies
  • Blogs
  • Contact Us

Our location

Hartford
.
Sydney
Gurgaon

Thelansis © 2026. All Rights Reserved

By browsing this website, you agree to our privacy policy.
I Agree